AI in Healthcare Research Internships
AI in Healthcare Research Internships
The University of Toronto’s Master of Science in Applied Computing Program (MScAC) is inviting industry partners and hospitals to participate in a unique opportunity to host computer science graduate students for 8-month applied research internships.
MScAC students are trained in AI in healthcare and life sciences, and possess strong technical skills in machine learning, data science, computational biology/informatics, and software engineering, and are seeking real-world challenges in healthcare. Utilize MScAC expertise to solve complex technological challenges, pilot innovative ideas through rapid prototyping and proof of concept development, and build, test, and evaluate models using state-of-the-art tools, frameworks, and methods. The MScAC program has a partnership with Mitacs that can be leveraged to help subsidize internships for eligible partners.
Timeline:
Internships take place from May 2026 – December 2026. Project submission opens October 14th, 2025.
Application Process:
If you are interested in participating and/or learning more, please email Daniele Chirico or the team.
C2MP – Canada Chicago Mentoring Program
C2MP – Canada Chicago Mentoring Program
The Trade Commissioner Service (TCS) is partnering with MATTER, the leading life sciences and healthcare incubator in Chicago, to deliver the Canada-Chicago Mentoring Program (C2MP). The program will provide strategic guidance through team-based mentoring to five Canadian start-ups in the C2MP cohort. Accepted applicants will benefit from mentoring and guidance to sharpen their go-to-market strategy.
Selected businesses will participate in an 8-month mentoring program that includes:
a virtual day of acceleration
monthly meetings with your dedicated mentoring team
educational workshops
an in-person pitch presentation at the end of the program
This program is hybrid, with at least one visit to Chicago as well as virtual meetings from February to September 2026.
Application deadline: October 24, 2025.
Build your best team yet: Become an I.D.E.A.L. Bioscience Employer in 2026
Build your best team yet: Become an I.D.E.A.L. Bioscience Employer in 2026
In today’s job market, people want more than pay. They want flexible work arrangements, a culture of belonging, strong leadership and opportunities for growth and learning. These are some of the everyday practices recognized by BioTalent Canada’s I.D.E.A.L. Bioscience Employer Recognition Program.This program lets you confidently and credibly brand your workplace as more than just a job. It shows employees you provide careers where they want to grow and belong.
The deadline to apply is November 28, 2025.
Apply to the Merck Digital Sciences Studio
Apply to the Merck Digital Sciences Studio
Applications are now open for our 2026 cohort!
The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.
Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.
Apply before November 28.
Industry-based internships in the regenerative medicine sector
Industry-Based Internships in the Regenerative Medicine Sector
The SCN-Mitacs industry-based internship partnership aims to pair the brightest graduate students and postdoctoral fellows with RM-focused biotech companies that are moving innovative therapies and technologies into the marketplace. This internship partnership is offered through the Mitacs Accelerate program and will match candidates with Canadian companies to complete an eight-month internship. Successful candidates will gain exposure to and work experience in industry and develop fundamental technical and business skills by undertaking a stem cell and regenerative medicine-related project.
Fill this expression of interest by December 5.
StartUps in the 6ix 2025
StartUps in the 6ix 2025
StartUps in the 6ix is back for its 3rd rendition! Come out and join the digital health emerging leader and startup community for an exciting night of learning and connecting. We’ll have a fireside chat featuring Tomi Poutanen, CEO, Signal 1, moderated by Joshua Liu, CEO and Co-Founder of SeamlessMD, followed by a startup expo to feature digital health startups in the Ontario ecosystem!
Call for proposals: Computer-Assisted Navigation Systems for Total Hip and Total Knee Arthroplasty
Call for proposals: Computer-Assisted Navigation Systems for Total Hip and Total Knee Arthroplasty
Through the Health Innovation Pathway, Ontario Health is launching a time-limited technology project to expand access and further understand the benefits of adopting computer-assisted navigation systems for total hip and/or total knee arthroplasty in patients with chronic and debilitating end-stage arthritic conditions in Ontario.
Health service teams based in community or academic Ontario hospitals currently performing hip and/or knee arthroplasty without computer-assisted navigation systems can receive up to $5,000,000 for capital, operating and associated administrative costs
How to submit a proposal:
Proposal template and submission details can be found in the online application form.
For questions about the submission of proposals, please contact HealthInnovationPathway@ontariohealth.ca.
Application deadline: May 29, 2026.
CanExport SMEs is now accepting applications
CanExport SMEs is now accepting applications
The CanExport SMEs (small and medium-sized enterprises) program offers competitive funding to help eligible Canadian small and medium-sized enterprises expand into new international markets.
The program supports businesses by sharing the costs of export-related activities, helping reduce risk and support export diversification. It is intended for companies with meaningful economic ties to Canada, the capacity to grow internationally, and a clear plan to export Canadian goods and services.
Successful projects may receive up to $50,000 in funding for international business development activities. Funding is limited, and applications are assessed on a rolling competitive basis.
Application deadline: May 29, 2026.
Developing Medicines through Open Science (DMOS)
Developing Medicines through Open Science (DMOS)
The Developing Medicines through Open Science (DMOS) program offers support and partnership opportunities for preclinical and clinical drug development in areas where open sharing and collaboration are key to advancement and where market solutions are limited.
This program aims to foster collaborations that undertake preclinical and clinical work to develop drug candidates in areas of unmet medical need, establish proof of concept (POC) for an open science path to drug development and further translate innovations into affordable medicines, generate economic activity, and support small and medium-sized enterprises (SMEs) in Canada.
For any program-related questions, write to Senior Program Manager, Resham Chhabra.
Canada – South Korea 2026-2027 collaborative industrial research and development call for proposals
Canada – South Korea 2026-2027 collaborative industrial research and development call for proposals
This competitive call for proposals is open to organizations from Canada and South Korea that wish to form project consortia to conduct collaborative projects focused on developing innovative products, processes, or technology-based services in the sectors identified below.
Application deadlines:
Canadian registration deadline: April 7, 2026
Canadian expression of interest deadline: April 21, 2026
International consortium project proposal deadline: June 26, 2026
Sectors of focus:
This call for proposals is open to projects in the following sectors:
Advanced manufacturing, including smart factory and smart manufacturing, advanced materials, automotive manufacturing, robotics and automation
Clean technologies, including water and wastewater management, smart grid and energy storage, battery-related technologies, renewable energy, hydrogen technologies and carbon management.
Digital technologies, including artificial intelligence for industry, cybersecurity, smart vehicle, and smart cities.
Health and biosciences, including pharmaceuticals, digital health, medical devices and mobile health.
Quantum technologies, including quantum computing, quantum communication, quantum sensing, cryptography, imaging, security, and quantum materials.
SCN's Silver Anniversary Awards
SCN's Silver Anniversary Awards
For 25 years, the Stem Cell Network has worked to transform lives through regenerative medicine in Canada — and people are at the heart of that progress.
Researchers, trainees, clinicians, volunteers, partners, and patient champions have driven discovery, translation, and impact across the country. Their ideas, leadership, and commitment have not only moved the field forward, but have also shaped SCN itself and sustained our work for a quarter century.
To mark this milestone, they are presenting the Stem Cell Network’s 25th Anniversary “25 for 25” Silver Anniversary Awards, honouring 25 outstanding individuals or groups whose contributions have strengthened Canada’s regenerative medicine ecosystem and helped define SCN over the past 25 years.
Help recognize excellence in Canada’s regenerative medicine community by nominating a colleague, organization, or group for one of five award categories.
Funding Available for Your Biopharmaceutical Projects
Funding Available for Your Biopharmaceutical Projects
Quantum Leap supports SMEs and universities in carrying out translational biopharmaceutical research projects aimed at developing technologies relevant to the R&D activities of CQDM’s pharmaceutical members.
Next application deadline: May 14, 2026.
For more information, please write to Jesse Paterson.
Funding Opportunity to Support Innovation in Quebec’s Biopharma Sector
Funding Opportunity to Support Innovation in Quebec’s Biopharma Sector
The biopharmaceutical R&D funding program is designed to support innovation in Quebec companies through the implementation of research projects in collaboration with Quebec's public research centres.
Next application deadline: June 6, 2026.
For more information, please write to Mathieu Paquette.
RESI 2026
RESI San Diego - June 22
Virtual Partnering - June 23 & 24, 29 & 30, 2026
OBIO® members can access exclusive discount codes by logging into the member portal.
RESI Boston - September 22-23
Virtual Partnering - September 25, 28-29, 2026
Announcement of Opportunity (AO) for Health and Life Science (HLS) Research on International Space Station (ISS) (ISS AO 2026)
Announcement of Opportunity (AO) for Health and Life Science (HLS) Research on International Space Station (ISS) (ISS AO 2026)
The Canadian Space Agency (CSA) is interested in human spaceflight and maintaining a healthy and highly qualified astronaut corps capable of participating in space exploration missions. Also, the CSA aims to enable scientific opportunities and global partnerships, and to harness space to solve everyday challenges for Canadians.
To support this goal, the CSA's Health and Life Sciences (HLS) group supports activities generating knowledge in fields that sustain human space flights, mitigate health risks, and lead to countermeasures for those missions. Canadian utilization of the International Space Station (ISS) focuses on research that addresses health risks of spaceflight. Eligible proposals must lead to a better understanding of these risks or generate information supporting the development of countermeasures.
AO Objectives:
Through this AO, the CSA is seeking to financially support Canadian researchers who will design and implement scientific protocols to investigate health risks associated with space travel. More specifically, submitted projects shall clearly demonstrate that they:
Contribute to the understanding, mitigation or elimination of health risks associated with human space flight.
Contribute to a better understanding of similar health issues or applications on Earth.
Propose innovative space life science studies to be conducted on the ISS using non-human research models.
Foster training of highly qualified personnel (HQP) in space health and life sciences.
Applications due July 24, 2026.
National Research Council Canada - Eureka Network Canada Call for Proposals (Winter-Spring 2026)
National Research Council Canada - Eureka Network Canada Call for Proposals (Winter-Spring 2026)
Canadian SMEs and other Canadian organizations in all sectors of focus are invited to apply to co-innovate with partners from any of 40+ Eureka member countries and gain access to global supply chains and new markets, technologies, and skills.
Registration deadline (Canadian SME applicants only): April 30, 2026.
BioTalent Canada’s Recruitment and Retention Solutions
BioTalent Canada’s Recruitment and Retention Solutions
BioTalent Canada’s Recruitment and Retention Solutions provide employer supports that help reduce the financial risk of hiring, while enabling organizations to benefit from the fresh perspectives, skills, and talent students bring to the table.
In fact, 59.3% of surveyed employers report that access to the creativity, knowledge, and skills of post-secondary students is the main benefit of BioTalent’s employment support programs, such as the Student Work Placement Program.
One example is the Science Horizons Youth Internship Program, which helps employers hire post-secondary graduates for environment-related STEM roles.
Whether you’re planning your next hire or exploring available supports, BioTalent Canada offers solutions designed to meet you where you are.
Explore available supports to help you hire or connect with our team to learn more.
For more info, write to Soufiane.
PwC Scale Program Cloud in Healthcare
PwC Scale Program Cloud in Healthcare
The program is designed to help international founders:
De‑risk market entry into Germany and Europe through hands‑on local GTM, regulatory, and compliance expertise
Use certification and regulation (e.g. BSI C5, DiGA pathways) as a competitive advantage rather than a blocker
Gain direct access to corporates, clinics, and ecosystem partners at the right moment, shortening sales cycles in regulated environments
Leverage Germany as a launchpad - once solved here, scaling across Europe becomes significantly easier
For more information, check out this brochure.
AI-driven Medicines (AIM)
AI-driven Medicines (AIM)
The AI-driven Medicines (AIM) program aims to drive transformative research that leverages computational or digital-based methods and tools to address critical, real-world challenges in the discovery and development of accessible and affordable medicines. This initiative focuses on supporting the development of innovative methodologies and tools to accelerate the drug discovery and development pipeline, bridging the gap between advanced computational theory and practical therapeutic applications.
Application deadline is December 31, 2026.
Applications open for DayOne Accelerator
Applications open for DayOne Accelerator
The DayOne Accelerator 2026 call for applications is now open! The program supports Swiss and international early-stage healthtech and techbio startups developing solutions that accelerate pharma R&D.
Program overview:
· 3-month hybrid accelerator based in Basel, Switzerland
· Access to pharma experts and Basel’s leading life sciences network
· 1:1 mentorship to refine your pharma-specific value proposition
· Equity-freeand fee-free program
· Post-program support through DayOne NEXT: up to CHF 50K cash grant, up to CHF 50K services, 12 months office space (conditions apply)
Who should apply:
Early-stage healthtech and techbio startups (Pre-Seed to Series A, <$10M dilutive funding raised) building solutions for pharma R&D and looking to collaborate or partner with pharmaceutical companies.
Join the “Ask Me Anything” webinar on May 7, 16:00–17:00 CET. Register here.
Application deadline: May 31, 2026.
Applications for the UTEST program are now open
Applications for the UTEST program are now open
The University of Toronto Early-Stage Technology (UTEST) program provides support to U of T entrepreneurs to create research-based companies. In partnership with Toronto Innovation Acceleration Partners (TIAP) and with the financial support of the Connaught Fund, it provides companies with investment capital, mentoring, business strategy and incubation space at the University of Toronto St. George Campus.
Deadline for all submissions is May 14, 2026.
Applications Open for the Platinum Program
Applications Open for the Platinum Program
TIAP has partnered with Mission BioCapital on their Platinum Program, with winners of their Platinum Ticket receiving up to $500K in pre-seed capital, lab space at the new BioLabs University of Toronto and mentorship from the accomplished MBC team and their amazing slate of sponsors.
Applications open until May 15, 2026.
Free workplace sexual harassment courses for bio-economy employers
Free workplace sexual harassment courses for bio-economy employers
Workplace sexual harassment can affect everything that matters in an organization: people, productivity, and reputation. You may not think about it every day, but someone on your team might. Many workers never report what they experience, often because they fear consequences or believe nothing will change (Respect at Work, 2021).
BioTalent Canada offers free, bilingual workplace sexual harassment courses designed specifically for SMEs in Canada’s bio-economy. Developed with legal experts and informed by employers and employees, the training reflects real-world situations in labs, offices and on teams like yours.
In two self-paced, 45-minute sessions, participants learn how to: recognize and prevent sexual harassment, respond in a safe, trauma-informed way and strengthen trust and productivity across their organization. These practical, flexible courses are built for busy leaders and teams. Employers can start when it works for them and begin making their workplaces safer the same day.
IPx Ontario 2026: Strengthening innovation during changing times
IPx Ontario 2026: Strengthening innovation during changing times
Join Ontario's intellectual property (IP) event of the year, presented by Intellectual Property Ontario (IPON). Join this invitation‑only event preceding the opening of DiscoveryX to hear from unicorn‑status innovators about their journeys of building and scaling operations in Ontario and beyond, as well as strengthening Team Ontario during this pivotal time. With IP at the core of protecting made‑in‑Ontario innovations, IPON is proud to convene this flagship event with partners from across Canada.
Dr. Maura Campbell, President and CEO of OBIO®, will be attending the event.
Sweet Biopharma Day
Sweet Biopharma Day
The 5th edition of Sweet Biopharma Day will be held on April 29, 2026, offering 16 Canadian start-ups the opportunity to present their research projects to major players in the pharmaceutical industry, investors and life sciences organizations. This event is an essential networking platform!
Parnian Tajbakhsh, Senior Manager, Capital Access at OBIO®, will be attending the event.
DiscoveryX
DiscoveryX
DiscoveryX is Canada’s premier innovation event, hosted by Ontario Centre of Innovation (OCI). Each year, DiscoveryX brings together entrepreneurs, investors, researchers, government, and industry leaders to showcase the power of Ontario innovation. Hosted in Toronto, DiscoveryX is Where Next Happens in Ontario.
Dr. Maura Campbell, President and CEO of OBIO®, will be part of the panel “Agentic AI in Pharma Manufacturing Excellence” on April 30.
STERIS Master Class: Applied Cleaning Validation
STERIS Master Class: Applied Cleaning Validation
The STERIS Master Class: Applied Cleaning Validation is an intensive, hands-on course designed to tackle real-world challenges in biomanufacturing. Learn current best practices, regulatory expectations, and validation strategies while gaining practical experience in a GMP-simulated environment.
AbbVie Partnering Day
AbbVie Partnering Day
AbbVie, in collaboration with BIOQuébec, will host a Partnering Day, bringing together researchers, entrepreneurs, and biotech companies from Canada.
AbbVie’s Partnering Days provide an opportunity to access senior level Corporate Business and Strategy Office (CBSO) representatives:
Meet with our research and partnership leadership teams to discuss your ideas and research in a one-on-one setting
Learn more about our strategy, approach to partnering and areas of interest (Immunology, Oncology, Neuroscience, Eye Care, Obesity and Aesthetics)
Learn about the investment strategy of AbbVie Ventures
This is an invite-only/exclusive event.
Parnian Tajbakhsh, Senior Manager, Capital Access at OBIO®, will be attending the event.
AbbVie Partnering Day
AbbVie Partnering Day
AbbVie Partnering Day – Montreal, Thursday, April 30, 2026
AbbVie, in collaboration with BIOQuébec, will host a Partnering Day in Montreal on April 30, 2026, bringing together researchers, entrepreneurs, and biotech companies from Canada.
AbbVie’s Partnering Days provide an opportunity for these groups to access senior level AbbVie Corporate Business and Strategy Office (CBSO) representatives:
Meet with our research and partnership leadership teams to discuss ideas and research in a one-on-one setting
Learn more about our strategy, approach to partnering and areas of interest (Immunology, Oncology, Neuroscience, Eye Care, Obesity and Aesthetics)
Learn about the investment strategy of AbbVie Ventures
AGENDA
Morning: One-on-one partnering meetings with pre-selected companies
Companies must apply in advance and be approved for a one-on-one partnering meeting. Meeting requests should be sent here. (Deadline April 3, 2026).
Afternoon: AbbVie Showcase & Networking Reception- overview of AbbVie’s strategies and external innovation priorities; AbbVie’s approach to partnering
Companies must register at the below link and be approved to attend the showcase and the reception (deadline to register April 15, 2026)
Webinar on US/Canada Medtech at a Crossroads: Navigating the ever more turbulent waters in the US market today
Webinar
US/Canada Medtech at a Crossroads: Navigating the ever more turbulent waters in the US market today
The Canadian Consulate General in Minneapolis, Minnesota, is organizing a webinar designed to be of interest to life science companies currently building their business in the US market and/or planning to enter the US market.
Time: Tuesday, May 5, 2026 at 10:00 AM CST
Duration: One-hour
Two veterans of medtech market research, product development, commercialization, acquisitions/due diligence, investor relations, and policy advocacy will deliver this webinar:
Frank Jaskulke (Presenter), Vice President of Business Development and Sales, Avio Medtech Consulting, Minneapolis, Minnesota; and
Joe Hofmeister (Host), Trade Commissioner, Life Sciences, Canadian Consulate General, Minneapolis, Minnesota
Given the current challenges facing Canadian life science companies seeking to establish/grow their business in the US market, this webinar may be timely. The following topics will be addressed:
1. US Go-to-Market Considerations
2. Managing the Tariff Situation
3. Managing Chaos in relevant US Agencies
a. FDA
b. CDC
c. NIH
d. CMS
e. Other?
4. Impacts on Canadian Companies Selling into the US
5. Guidance/Next Steps
6. Extended Q & A session
Click here to join the webinar.
Meeting ID: 236 144 846 816 78
Passcode: BW6oB3QQ
Deadline to confirm your attendance for the webinar is Friday, May 1. Interested companies can reach out to Aude-Alexia Véronneau, Zinnia Jamshed and Abigail Sobin.
TCS in New York: North American commercialization accelerator at Hackensack Meridian Health
Webinar
TCS in New York: North American commercialization accelerator at Hackensack Meridian Health
The Trade Commissioner Service and Government of Ontario's Trade & Investment Office in New York City invite you to join an exclusive webinar with Hackensack Meridian Health to learn about Emerge 2026, their North American innovation program designed to accelerate the commercialization of high‑impact healthtech solutions.
At a glance:
Date & time: May 6, 12:00-01:00 pm ET
Goal of the event: Emerge connects select companies from Canada, the U.S., and Mexico with one of the largest health systems in the U.S. to pilot and scale solutions addressing priority clinical challenges, including postpartum maternal health and value‑based care delivery. This session will walk through HMH’s strategic priorities, the Emerge application process, and where Canadian healthtech companies may be uniquely well‑positioned to participate.
Who should attend: Companies with an interest in the US market, building a solution ready for real‑world clinical validation and cross‑border deployment.
Interested companies can reach out to Aude-Alexia Véronneau and Zinnia Jamshed.
Mexican Life Sciences Trade Mission to Canada
Mexican Life Sciences Trade Mission to Canada
This trade mission, organized by the Mexican government, will bring a delegation of Mexican companies seeking Canadian partners across 10 sectors. As part of the program, Canadian companies may have the opportunity to participate in pre‑arranged B2B meetings with Mexican firms interested in partnerships, sourcing, investment, and market expansion.
The Mexican Trade Mission to Canada will take place on:
May 7 - Toronto
May 8 - Montréal
This initiative may be of interest to companies looking to:
Diversify or strengthen North American supply chains
Explore commercial partnerships with Mexico
Engage with Mexican companies active in selected sectors (Infrastructure, Agro‑industry and agri‑food, Manufacturing and advanced manufacturing, Pharmaceuticals and life sciences, Energy, Logistics and transportation, Education and training services, Innovation and intellectual property (patents, R&D), Creative industries, Investment funds and financial services)
Canadian companies are invited to register their interest in participating in B2B meetings via the Mexico government’s official Mission website, here.
Please note that Mexico’s Secretariat of Economy is responsible for the mission’s business program elements and B2Bs. The TCS encourages interested companies to contact the Mexican organizers directly for any questions.
Ontario tech mission to Vancouver’s WebSummit
Ontario tech mission to Vancouver’s WebSummit
The Government of Ontario is considering organizing a Technology Export Business Mission to WebSummit in Vancouver for up to 30 Ontario tech firms. Ideal sub-sectors include AI & Quantum, Life sciences, Cleantech, Agritech, Oceantech, Creative, Proptech, Fintech. WebSummit is part of a global tech series that expects to attract 20,000 attendees and 800 investors from 100+ countries. Participation in this mission would offer Ontario companies an opportunity to showcase the province’s competitive advantage in the ICT sector to international partners, investors, and industry leaders. The program would feature two participation streams, both with value‑added programming such as a briefing on procurement and financing opportunities (May 4), a B2B matchmaking program (May 5), and participation at a networking session. The exact mission registration fee will be provided as part of the mission registration package; travel and accommodation are extra. There are two participation streams: Stream A: 1‑day turn‑key branded exhibit space with 1 pass for access all 3 days, plus value‑added programming; estimated cost: $800. Stream B: 3-day turn‑key branded exhibit space 3 passes for access all 3 days, plus value‑added programming; estimated cost: $2,500.
Deadline to apply (priority for first applicants): March 13, 2026. Submit your Expression of Interest to Expression of Interest - Ontario tech mission to WebSummit, May 11-14, 2026 – Fill out form.
For more information, please contact Mauricio Ospina.
Canadian Life Sciences Trade Mission - New York and New Jersey
Canadian Life Sciences Trade Mission - New York and New Jersey
The Canadian Trade Commissioner Service in New York, in collaboration with provincial governments, is organizing a life sciences trade mission to the New York and New Jersey corridor - home to the largest concentration of pharma, biotech, and life sciences decision-makers in the United States.
This mission is designed for Canadian companies looking to build partnerships, explore market opportunities, and make meaningful connections with US industry leaders across the life sciences ecosystem.
Deadline to apply is Friday, May 1.
The Art of Leadership Women Toronto
The Art of Leadership Women Toronto
In a world of information overload, The Art of Leadership Women focuses on the topics and trends most critical to leaders. This unique one-day conference features a riveting collection of world leaders, business icons, academics, and bestselling authors who inspire action.
Attendees will have the opportunity to learn improved ways of leveraging their value, elevating their skills, and developing the strategies required to take their leadership and their organizations to the next level. This conference is not just for women, but for anyone who wants to champion change on behalf of women.
2026 Seneca Applied Research Symposium
2026 Seneca Applied Research Symposium
This half-day event will take place at Newnham Campus on Tuesday, June 2 from 9 a.m. to 1:30 p.m. The event will feature a keynote, a fireside chat, and engaging breakout sessions, concluding with a networking lunch and an exhibit showcasing applied research projects. This year's keynote will be delivered by Daniel Carson, Co-founder of Goldy's, who will take us through the journey of building their Toronto-based breakfast product company that was selected to send its cereal into space as part of the Artemis II mission.
Full agenda and registration details will be available soon.
If you have any questions, please contact the team.
Canada's Medtech Conference 2026 - Health Innovation: Healthier Canadians, Stronger Economy
Canada's Medtech Conference 2026
Health Innovation: Healthier Canadians, Stronger Economy
Join leaders from across the health care ecosystem for an engaging and forward-thinking event focused on driving health innovation in Canada. This conference will explore how adopting cutting-edge technologies and innovative practices can improve patient outcomes, strengthen our health care system, and contribute to a more resilient economy.
Key Discussion Areas:
✔ Adopting Health Innovations
✔ Procurement & Policy Perspectives
✔ Patient-Centered Innovation
✔ Artificial Intelligence in Health Care
✔ Building System Resilience
Defence Export Mission to Eurosatory 2026
Defence Export Mission to Eurosatory 2026
The Government of Ontario is organizing a Defence Export Mission to Eurosatory 2026, the world’s leading international exhibition for land and air-land defence and security industries. Held every two years in Paris, France, Eurosatory brings together global defence manufacturers, military officials, government delegations, and security professionals to showcase cutting-edge technologies and build strategic partnerships. Exhibiting in the Ontario Pavilion at the Eurosatory 2026 will provide Ontario companies with direct access to international buyers, defence procurement agencies, system integrators, and distribution partners from Europe, the Middle East, Asia, the Americas, and other global markets.
The mission program will include pre-mission webinars, 1:1 export advice and consultation, a turn-key kiosk/pod exhibit space, a company listing on the show directory, access to conference sessions, and shared Ontario Pavilion amenities such as dedicated areas for private meetings, daily cleaning, waste removal, and more. Exhibit spaces in the Ontario Pavilion are limited and will be given to companies that have registered and paid in full, on a first come, first served basis.
Mission Registration Fee: $4,500 CAD (taxes included). Upon acceptance into this mission, you will be sent a link to complete the registration process and submit payment.
Apply by: March 23, 2026 at Ontario Export Business Missions | Application Form.
For more information, please write to Michael Shklyar.
Ontario at BIO 2026
Ontario at BIO 2026
The Ontario government in collaboration with the Ontario Trade and Investment Office in San Francisco, and the Trade Commissioner Service, invites you to join the Ontario Export Business Mission to the Biotechnology International Convention (BIO). BIO serves a major link connecting Ontario life sciences companies with potential partners, customers and investors from the US and international markets. Located in Washington, DC, BIO is the most prominent organization dedicated to life sciences/biotechnology. The focus of this mission will be on the 3-day BIO business partnering program. While this program does not include and exhibit opportunity, Invest Ontario will have a presence in the exhibition hall that will serve as a convenient meeting place for mission participants. BIO regularly attracts over 20,000 international attendees.
The mission program will include the following:
Pre-event webinars delivered by the BIO staff
Full access to the BIO business partnering, conference educational sessions
Networking events
1:1 consulting
Listing in the Ontario Directory of Exhibitors
Preferred hotel rates
On-site assistance throughout the event
Mission Registration Fee: CAD $1175.00.
Apply by: March 19, 2026.
To apply and for more information, please write to Patricia Cosgrove.
Healthcare Collaboration Forum 2026
Healthcare Collaboration Forum 2026
The Healthcare Collaboration Forum, organized by Medtech Canada in collaboration with Santé Québec, will bring together key healthcare stakeholders around innovations that are transforming how we deliver healthcare. Over twenty innovative medtech companies will present their solutions and innovations to over one hundred qualified attendees from across the province.
This first edition will be a unique chance for healthcare professionals, researchers, institution managers, and public and private decision-makers, to learn about innovative solutions from the industry players. It is fully aligned with this mission and will provide a unique platform for us to meet, share, and co-construct solutions so that we can collectively tackle Canada’s current and future health challenges.
Mission BioCapital Platinum Program Office Hours at BioLabs University of Toronto
Mission BioCapital Platinum Program Office Hours at BioLabs University of Toronto
Mission BioCapital is committed to helping bold biotech entrepreneurs bring transformative science to life. Check out their Office Hours for applicants to their 2026 Platinum Program! This is a great opportunity to get your questions answered, and learn how to best position your venture for success.
During the Office Hours, you’ll have a chance to:
Ask direct questions about the application process and eligibility
Learn what makes a strong Platinum Program candidate
Hear what to expect from the program and how to make the most of it
Intellectual Property Ontario launches new IPON Portal
Intellectual Property Ontario launches new IPON Portal
Intellectual Property Ontario (IPON) has launched its new IPON Portal, making it easier for Ontario founders to access trusted IP support. With applications now open, innovators can connect with expert guidance to protect, strengthen and commercialize their IP with confidence. The redesigned portal offers personalized dashboards, tiering assessments, integrated learning modules and clearer pathways to programs and resources - everything you need to move your IP strategy forward.
Live client Q&A sessions
To help clients get familiar with the IPON Portal, IPON will be hosting Q&A sessions that you are welcome to attend if of interest:
MaRS Impact Health
MaRS Impact Health
MaRS is hosting its annual health tech summit Impact Health on April 23. The Summit brings together innovators across digital health, medical devices, and biotech to commercialize new breakthroughs, empower our healthcare workers, and improve patient outcomes.
OBIO® is pleased to be a sponsor of the 2026 MaRS Impact Health.
Women Driving Health Innovation: Celebrating Excellence in Entrepreneurship
Women Driving Health Innovation: Celebrating Excellence in Entrepreneurship
Health Innovation Hub (H2i) at the Temerty Faculty of Medicine and the Schwartz Reisman Innovation Campus Ecosystem team invite you to an engaging afternoon celebrating incredible women leaders in health innovation!
Hear from the next generation of women health entrepreneurs through H2i’s annual FemSTEM Pitch Competition, featuring expert judges Denise Belsham, Dr. Fahima Osman, Garima Ghale and Jessica Galli.
Explore emerging opportunities and crucial considerations for AI in women’s health, through an engaging panel. Founders Dr. Nardin Samuel and Parnian Majd and subject matter experts Rachel Katz and Sarah Farr will be joined by moderator Ayesha Rashid.
Immerse yourself in the ecosystem of women-led health innovations through a dynamic start-up showcase.
Garima Ghale, Associate Director, Programs & Strategic Partnerships at OBIO®, will be among the judges for the FemSTEM Pitch Competition.
Ontario ICT Export Business Mission to World IT Korea with Outreach to Japan
Ontario ICT Export Business Mission to World IT Korea with Outreach to Japan
Ontario is leading an ICT Export Business Mission to World IT Korea 2026 (April 22-24, 2026) in Seoul, South Korea at COEX Convention Center. Hosted by KITA, KAIT, and supported by the Korea Ministry of Trade, Industry and Energy, the World IT Show Korea is a leading international exhibition for Artificial Intelligence, Internet of Things, Telecommunication, Digital Twins, e-commerce, Smart Living & Health Care, Robotics, Intelligent Mobility, Cybersecurity and Quantum technology.
Fee: C$1,500 per company. B2B Matching Meeting: C$1,500 per company.
For more information, please reach out to the team.
BIOTECanada Innovators & Industry: Biotech Networking Evening
BIOTECanada Innovators & Industry: Biotech Networking Evening
Join BIOTECanada and Baker McKenzie for the Innovators & Industry: Biotech Networking Evening, a cocktail reception hosted alongside the Bloom Burton & Co. Healthcare Investor Conference (BBHIC).
This dynamic gathering brings together leaders and emerging talent from across Canada’s biotech landscape. Connect with executives, investors, pharma and BD professionals, legal and advisory partners, and other industry influencers driving innovation forward.
Dr. Mary Argent-Katwala, Senior Director, Stakeholder Engagement at OBIO®, will be attending the event.
Bloom Burton & Co. Healthcare Investor Conference
Bloom Burton & Co. Healthcare Investor Conference
The Bloom Burton & Co. Healthcare Investor Conference takes place annually at the Metro Toronto Convention Centre (North Building). Join Canadian, U.S. and international investors who are interested in the latest developments in Canadian healthcare companies. Investors have the opportunity to obtain corporate updates from presenting companies, and certain investors will be invited to participate in our 1-on-1 meeting system with company management.
Dr. Maura Campbell, President and CEO of OBIO® and Parnian Tajbakhsh, Senior Manager, Capital Access at OBIO®, will be attending the conference.
National Health-Tech Innovation Conference
National Health-Tech Innovation Conference
The third annual National Health-Tech Innovation Conference is happening in Kitchener-Waterloo this April.
Join influential decision-makers, funders, clinicians, and innovators to break through bottlenecks and design practical, scalable solutions in health care. Expect two days of networking, hands-on problem-solving, facilitated high-value discussions, and strategy-building sessions that lead to real impact in Canadian health care.
Bibaswan Ghoshal, Senior Director, Technology Adoption at OBIO®, will be speaking at the conference.
Early‑Stage Life Sciences Matchmaking Day
Early‑Stage Life Sciences Matchmaking Day
Join an exclusive matchmaking experience designed for top Canadian and US investors, global pharma, and high-potential, emerging life sciences companies primed for their next deal. Through curated 1:1 meetings, attendees gain direct access to untapped networks, strategic partners, and opportunities that drive cross-border deal flow and accelerate growth.
Investors and pharma: Discover promising companies aligned with your investment criteria.
Companies: Connect with investors positioned for your stage, industry, and capital-raising goals.
Register early to secure your priority meetings, expand your network across key innovation hubs, and start meaningful deal-making conversations that extend well beyond the day itself.
Dr. Maura Campbell, President and CEO; Christina Yeh, Vice President, Programs & Strategic Partnerships; and Parnian Tajbakhsh, Senior Manager, Capital Access at OBIO®, will be attending the event.
LSO Knowledge and Networking Breakfast - Health System Readiness in the Era of Cell and Gene Therapy - From Benchtop to Bedside
LSO Knowledge and Networking Breakfast - Health System Readiness in the Era of Cell and Gene Therapy - From Benchtop to Bedside
This discussion will focus on the adoption of cell and gene therapies within the health system and explore the path from discovery to delivery, including the commercialization challenges of scaling therapies from benchtop to clinic, emerging innovations such as antibody–drug conjugates and personalized medicine, and the evolving Canadian investment landscape supporting the growth of advanced therapies.
Dr. Mary Argent-Katwala, Senior Director, Stakeholder Engagement at OBIO®, will be attending the event.
Falcons’ Fortunes Pitch Competition
Falcons’ Fortunes Pitch Competition
FACIT’s annual Falcons’ Fortunes event features six Ontario entrepreneurs vying for the $100,000 award in the province’s only pitch competition specifically showcasing cancer breakthroughs. Join and put on your investor hat to vote for your favourite pitch presentation to win the Audience Choice award.
Now in its 13th year, Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community. FACIT is cultivating entrepreneurial scientists who will drive a culture of commercialization to accelerate the transformation of Ontario’s cancer research into Ontario-made solutions to improve patient care.
Dr. Maura Campbell, President and CEO of OBIO®, will be attending the pitch competition.
MedTech Leadership Night
MedTech Leadership Night
Join ventureLAB on April 14, 2026 from 4:00-5:00 PM for MedTech Leadership Night, hosted by Nima Khadem Mohtaram, Head of MedTech Initiatives. Featuring Dr. Saumik Biswas (Tenomix Inc.) and Dolma Tsundu (Flutter Care), this session brings real stories, honest lessons, and practical insights from the front lines of building MedTech ventures.
Tenomix and Flutter Care are OBIO-affiliated companies.
Webinar: Taiwan Life Sciences Opportunities & Bio Asia–Taiwan 2026
Webinar
Webinar: Taiwan Life Sciences Opportunities & Bio Asia–Taiwan 2026
This webinar is designed to help Canadian biotech, pharma, medtech, digital health and biomanufacturing companies better understand the rapidly growing life sciences market in Taiwan and explore opportunities to participate in BIO Asia-Taiwan 2026 (July 15-19, 2026), one of Asia’s most influential industry conferences and exhibitions.
Register by April 6.
Webinar I Trade Commissioner Service – Indonesia
Webinar
Trade Commissioner Service – Indonesia: Explore Opportunities and Healthcare Market
This webinar will explore opportunities for Canadian companies interested in participating in the Indonesia Int’l Hospital Expo 2026 (October 7-10, 2026). The Indonesia Int’l Hospital Expo is one of South-east Asia’s leading healthcare trade exhibitions, showcasing hospital and medical equipment, healthcare technology, pharmaceuticals, and laboratory solutions.
Register by March 30.
Connect-Bio: Quebec Forum on Biofabrication
Connect-Bio: Quebec Forum on Biofabrication
The PROTEO strategic cluster and the CQDM invite you to their event: Connect-BIO: Quebec Forum on Protein Biofabrication. A must-attend event fostering networking and collaboration between academia and industry.
On the agenda:
🔬 Attend a panel discussion with industry experts. Names will be revealed soon – stay tuned!
💬 Exchange ideas, ask questions, and expand your knowledge.
🤝 End the day with a networking cocktail to broaden your network and connect with the industry ecosystem.
Ideas to Impact: Strengthening Community Innovation
Ideas to Impact: Strengthening Community Innovation
Ideas to Impact: Strengthening Community Innovation will take place on March 31, 2026, at Mohawk College’s Fennell Campus, bringing together industry partners, community organizations, funders, government and municipal leaders, and colleges for a half‑day of focused discussion on building capacity and adapting to new realities, in a climate of uncertainty. Running from 8:30 a.m. to 1:30 p.m., followed by a lunch and an optional tour of the research facilities, the event will explore how applied research continues to shape and strengthen innovation. Participants will engage with thought‑provoking panels tackling topics like the evolution & opportunities of Applied Research in southern Ontario, dual‑use in the 21st Century, and seeing how Applied Research intersects with tariffs.
Team Canada Trade Mission to the Republic of Korea
Team Canada Trade Mission to the Republic of Korea
The trade mission program will be targeted to the following sectors:
aerospace and defence
clean energy transition
information and communications technologies
life sciences
Interested Canadian SMEs must clearly demonstrate their operation in one of the specific sectors identified for this trade mission, be export-ready with demonstrated potential for success in the South Korean market, demonstrate that their product/service will generate economic benefits for Canada, and meet the eligibility criteria to qualify as a client of the Trade Commissioner Service.
Application deadline: February 13, 2026
Connect Bio *Expanded* | Bringing Together Canada’s Genomics Ecosystem
Connect Bio *Expanded* | Bringing Together Canada’s Genomics Ecosystem
Interested in genomics? Connect with strategic partners, funding opportunities, and cutting‑edge resources driving genomics innovation. For the first time, Connect-Bio is coming to Toronto.
CQDM, in partnership with NGen, invites you to Connect-Bio | Bringing Together Canada’s Genomics Ecosystem, a flagship event uniting Canada’s genomics, life sciences, and biopharmaceutical innovation ecosystem.
This Toronto edition will bring together companies and organizations active in genomics or interested in the field—from pharmaceutical companies to innovative startups and service providers, as well as research platforms and other strategic partners. The event is designed to foster meaningful exchanges and concrete collaboration opportunities.
Global Healthcare Innovation Summit
Global Healthcare Innovation Summit
The Global Healthcare Innovation Summit returns as the flagship convening of Future Health – A Global Initiative, led by Canadian and international partners.
The Summit brings together senior global decision-makers responsible for healthcare strategy, public policy, investment, and system transformation. Over two days, leaders from biotech, pharma, government, academia, healthcare systems, and capital markets will convene to address the most urgent challenges and transformative opportunities shaping the future of healthcare.
2026 Program Highlights
Cell Therapy
Cutting-edge CAR-T and antigen-specific T-cell therapies, with a focus on what is truly advancing into the clinic.Bispecifics & Multispecifics
Emerging T-cell engagers and next-generation antibody platforms for solid tumours and autoimmune disease.Therapeutic mRNA Vaccines
Real-world progress in vaccine design, immunogenicity, manufacturing, and scale-up.Radiopharmaceutical Innovation
Advances in targeted diagnostics and therapeutic applications.AI in Drug Discovery & Development
Using artificial intelligence to accelerate timelines, reduce risk, and improve clinical success.Canada–UK Biotech Symposium
Strengthening transatlantic collaboration, partnerships, and investment pathways.Non-Dilutive Funding for Biotech
Government, institutional, and strategic funding mechanisms supporting innovation.Venture Capital Outlook for Life Sciences
Current funding trends, market dynamics, and emerging opportunities.Dual-Use Technologies
Platforms with applications across healthcare, security, and defense.Organoids & Organ-on-a-Chip Models
Next-generation preclinical systems transforming translational research and drug development.Regulatory Landscape
Recent FDA announcements on clinical studies and their implications for biotech and life sciences companies.
Digital Health Canada ON26
Digital Health Canada ON26
This annual conference (formerly UpOnDigital: The Update on Ontario Digital Health) is an important date on the Ontario digital health calendar and the best place to connect with Ontario public and private sector leaders and innovators as they present updates on their work and plans for the future. ON26 offers informative sessions exploring the issues that matter most to Ontario patients, caregivers, and digital health professionals; the latest in Ontario StartUp innovators; and multiple networking opportunities.
Applications open for Centre for Aging and Brain Health Innovation’s Fuel program
Webinar
Applications open for Centre for Aging and Brain Health Innovation’s Fuel program
Centre for Aging and Brain Health Innovation’s (CABHI) Fuel program offers up to $500K CAD and acceleration services to help early- to mid-stage researchers and start-up companies achieve research, development, and validation milestones. This program is designed to remove common barriers that stall innovative solutions which have the potential to transform the aging experience.
Applications close on April 15.
Ontario Smart Tech & Embedded Systems Export Mission to Embedded World 2026
Ontario Smart Tech & Embedded Systems Export Mission to Embedded World 2026
Embedded World is the premier global trade fair for embedded technologies, attracting over 1,200 exhibitors and 32,000 visitors in 2025, with more than 40,000 participants expected in 2026. The event showcases the latest in embedded hardware, software, security, and IoT, featuring high-level conferences and workshops on emerging trends like edge computing, AI integration, and secure IoT applications.
Key exhibition areas include: Embedded Vision (optical systems, sensors, image processing), Electronic Displays (microLEDs, HMI, automotive displays), M2M Communication (LPWAN, NB-IoT, 5G), Safety & Security (functional safety, cybersecurity), IC & IP Design (chip and encryption design)
The embedded systems market is growing rapidly (CAGR 10–15% through 2030), driven by smart devices, AI, and Industry 4.0, offering unique export opportunities for Ontario companies.
Participation Includes:
One-on-one export advice and consultation
Market and sector briefings on European trends and opportunities
Turnkey co-exhibitor kiosk within the Canada Pavilion
Two exhibitor passes
Site visits and B2B matchmaking
Marketing and promotional support
On-site assistance during the trade show
Cost of Participation is CAD $4,560.
Applications open for OBI’s NERVE Program
Applications open for OBI’s NERVE Program
The NERVE (Neurotech Entrepreneurship to Validate Emerging Innovations) program is Canada's single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.
NERVE supports early-stage entrepreneurs developing innovative solutions in the brain health space, including neurotechnology, diagnostics, therapeutics, digital health, and enabling platforms with strong translational potential. The program is designed to help ventures validate their value proposition, strengthen their commercialization strategy, and accelerate readiness for investment and market entry.
Apply by April 27, 2026.
Panel & Networking Event: Digital Health Innovations & Cyber Risk in Life Sciences
Panel & Networking Event: Digital Health Innovations & Cyber Risk in Life Sciences
Join an engaging panel discussion and networking reception exploring digital health innovation and the evolving cyber risk landscape facing life sciences organizations. This timely conversation will bring together industry experts to share insights on risk management, governance, and emerging challenges.
Meet the Speakers
Moderator: Marcie Foster, Assistant Vice President, Senior Life Sciences Specialist, Chubb
Terri Ralff, Vice President, Territory Underwriting Manager, Life Sciences, Chubb
Karen Continenza, Senior Vice President, Cyber Claims Specialist, Marsh Risk
Following the panel, attendees are invited to stay for networking with wine and appetizers.
Ontario ICT Export Business Mission to Mobile World Congress (MWC) 2026
Ontario ICT Export Business Mission to Mobile World Congress (MWC) 2026
MWC Barcelona is the world’s largest and most influential annual exhibition for the mobile technology and connectivity industry with over 109,000 visitors from 205 countries and territories and over 2,900 exhibitors.
MWC provides an excellent showcase of Ontario mobile technology products, and solutions and provides companies with key opportunities to build business partnerships in the European market, with the intention of unlocking new export markets in Europe and increasing exports for Ontario companies already active in the markets.
MWC attracts some of the industry’s most important decision-makers and the show is regarded as the best place to find new clients and partners and to network with leading players in the mobile and communication technology industry worldwide.
The mission program will include:
• 1:1 export advice and consultation
• A pre-event Virtual Market Seminar
• Market and sector briefings to provide updates on trends and opportunities in key European markets
• Individual co-exhibitor turn-in ready kiosk within the Canada pavilion.
• 3 exhibitor passes
• B2B matchmaking and networking opportunities
• Marketing and promotional support
• On-site assistance during the trade show
Booth assignments are first-come, first-served based on payment.
The cost of exhibiting is CAD $ 4,851
Ontario ICT Export Business Mission to Mobile World Congress (MWC) 2026
Ontario ICT Export Business Mission to Mobile World Congress 2026
Mobile World Congress (MWC) Barcelona is the world’s largest and most influential annual exhibition for the mobile technology and connectivity industry with over 109,000 visitors from 205 countries and territories and over 2,900 exhibitors.
MWC provides an excellent showcase of Ontario mobile technology products, and solutions and provides companies with key opportunities to build business partnerships in the European market, with the intention of unlocking new export markets in Europe and increasing exports for Ontario companies already active in the markets.
The mission program will include:
• 1:1 export advice and consultation
• A pre-event Virtual Market Seminar
• Market and sector briefings to provide updates on trends and opportunities in key European markets
• Individual co-exhibitor turn-in ready kiosk within the Canada pavilion.
• 3 exhibitor passes and more
Webinar I Export to Market: Japan
Webinar
Export to Market: Japan
The Ontario Ministry of Economic Development, Job Creation & Trade (MEDJCT) is hosting a webinar event to allow interested companies to explore business opportunities in Japan. During this webinar speakers from both Ontario and Japan will discuss economic conditions, exporting & regulatory practices, and accessing this market, with a particular focus on accessing the Trans Pacific Partnership (TPP) free trade agreement. The objective of this event will be to provide companies with a ready understanding of exporting opportunities in Japan in order to engage with an important region of the global economy.
Applications open for CACHE Challenge #8: Finding ligands targeting GID4
Applications open for CACHE Challenge #8: Finding ligands targeting GID4
Applications are now open for CACHE Challenge #8, which invites participants to identify chemically novel molecules that bind to the substrate-recognition pocket of GID4, a protein involved in cellular protein quality control.
GID4 plays a role in the cell’s protein disposal system: it recognizes specific proteins that are damaged or no longer needed and directs them to the cellular protein degradation system. By selectively engaging this recognition process, researchers can potentially harness the cell’s own machinery to remove disease-causing proteins.
The deadline to apply is April 16, 2026.
Frontlines & Founders, 2nd edition - Reverse Pitch in Innovation
Frontlines & Founders, 2nd edition - Reverse Pitch in Innovation
L'Institut du Savoir Montfort invites you to present your vision and inspire other experts during this reverse pitch, where creative ideas converge into concrete solutions. Come present your innovative healthcare idea to an audience of industry leaders, investors, and collaborators in the healthcare innovation ecosystem, discuss opportunities for collaboration and partnership, and network with like-minded individuals in entrepreneurship, healthcare, and business.
Ontario AI Export Business Mission to World AI Cannes Festival
Ontario AI Export Business Mission to World AI Cannes Festival
World AI Cannes Festival (WAICF) 2026 will take place February 12–13, 2026. This elite event brings together a high-caliber mix of AI innovators, global tech leaders, fast-scaling startups, and enterprise decision-makers. Organized by the creators of Big Data & AI Paris, WAICF is purpose-built for real-world use cases, international B2B lead generation, and cross-sector strategic partnerships.
The 2026 edition is expected to feature: more than 10,000 business attendees; over 220 international exhibitors, including companies such as Google, Meta, NVIDIA, AWS, Airbus, Hugging Face, Alibaba, JP Morgan, and Accenture; 320+ global speakers from industry, academia, and public institutions; 600+ pre-arranged business meetings, powered by WAICF’s AI-driven matchmaking platform; and strong representation from key sectors: healthcare, fintech, cybersecurity, mobility, energy, manufacturing, retail, and government.
The Ontario Mission will include:
1:1 export advice and consultation
Market and sector briefings on key trends and opportunities in Europe
Site visits
Marketing and promotional support
On-site assistance during the trade show
Co-exhibitor plug-and-play kiosks within the branded Ontario/Canada Pavilion
Unlimited exhibitor badges (exhibit-only access for additional staff)
Company logo and profile featured on the official WAICF website
Unlimited access to the BBCM matchmaking platform, allowing direct B2B meeting scheduling with qualified attendees (exhibitors, visitors, and speakers)
Participation in a premium networking cocktail at the Majestic Hotel, engaging with high-profile delegates and decision-makers.
Booth assignments are first-come, first-served based on payment.
The cost to exhibit is CAD $3,900.